A research team partly funded by NHLBI found that stem cell lines grown in laboratories often acquire genetic mutations that could increase the risk of cancer in patients receiving transplants. The study was published in Nature.
The Scientist Magazine: Cell Lines Gain Cancer-Related Mutations
Technology.org: Staving Off Stem Cell Cancer Risk